WC
LEGN icon

Wexford Capital’s Legend Biotech LEGN Stock Holding History

Wexford Capital’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,062
Closed -$425K – 258
2023
Q4 		$425K Sell
7,062
-7,061
-50% -$447K 0.09% 108
2023
Q3 		$949K Hold
14,123
– – 0.21% 82
2023
Q2 		$975K Buy
+14,123
New +$923K 0.19% 77

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wexford Capital's LEGN Position: Q1 2024 in Review

Wexford Capital sold out of Legend Biotech (LEGN) in Q1 2024, closing a stake of 7,062 shares — an estimated $425K sold.

Wexford Capital first reported a position in LEGN in Q2 2023 and held it in 3 quarters. The position peaked at $975K in Q2 2023. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

  • Wexford Capital reported no remaining Legend Biotech position as of Q1 2024 after selling out during the quarter.
  • Wexford Capital sold 7,062 Legend Biotech shares in Q1 2024, an estimated $425K.
  • Wexford Capital first reported a position in Legend Biotech in Q2 2023 and held it in 3 quarters.
  • Wexford Capital's Legend Biotech position peaked at $975K in Q2 2023.
  • 192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Wexford Capital's 13F filing for Q1 2024, filed 15 May 2024.